Rosalind Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Rosalind Advisors, Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $119.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$119.4M
| Company | Shares | Value |
|---|---|---|
| SVRASavara Inc | 3,203,721 | $17.5M |
| PCVXVaxcyte, Inc. | 290,000 | $16.9M |
| XFORX4 Pharmaceuticals, Inc | 3,214,766 | $13.3M |
| VORVor Biopharma Inc. | 700,000 | $12.5M |
| VSTMVerastem, Inc. | 2,138,475 | $11.3M |
| CLDXCelldex Therapeutics, Inc. | 330,000 | $10.5M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 923,057 | $8.8M |
| CGONCG Oncology, Inc. | 100,000 | $6.8M |
| AVIRAtea Pharmaceuticals, Inc. | 1,171,855 | $6.3M |
| VRDNViridian Therapeutics, Inc.\DE | 250,401 | $4.9M |
| OVIDOvid Therapeutics Inc. | 1,107,994 | $2.5M |
| DFTXDefinium Therapeutics Inc. | 125,000 | $2.4M |
| OKUROnKure Therapeutics, Inc. | 443,763 | $1.8M |
| AVTXAvalo Therapeutics, Inc. | 75,000 | $1.1M |
| ANNXAnnexon, Inc. | 200,000 | $1.1M |
| AQSTAquestive Therapeutics, Inc. | 250,000 | $1.0M |
| KURAKura Oncology, Inc. | 100,000 | $813K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.